LAS VEGAS--(BUSINESS WIRE)--Kerecis, the company pioneering the use of sustainably sourced fish skin in cellular therapy and tissue regeneration, will present its clinically proven fish-skin graft ...
Real-world clinical trial shows superior clinical effectiveness of intact fish-skin grafts over standard care for treating severe, hard-to-heal Stage 3 and 4 pressure ulcers. Kerecis, the company ...
Kerecis, the company pioneering the use of sustainably sourced fish‑skin in tissue regeneration, announced today at the ...
ARLINGTON, Va. & REYKJAVIK, Iceland--(BUSINESS WIRE)--Kerecis, the company pioneering the use of sustainably sourced fish skin and fatty acids in cellular therapy and tissue regeneration, today ...
Kerecis, the company pioneering the use of sustainably sourced fish-skin in cellular therapy and tissue regeneration, will showcase its intact fish-skin technology and highlight new clinical data on ...
With this policy update, Kerecis fish-skin grafts — including the MariGen ® and Shield ® product lines — became available to tens of millions of additional Americans. In total, nearly 200 million ...
The MarketWatch News Department was not involved in the creation of this content. Real-world clinical trial shows superior clinical effectiveness of intact fish-skin grafts over standard care for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results